MariMed Inc. (MRMD.CN)
CAD 0.12
(-20.69%)
CAD 0.12
(-20.69%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 51.53 Million USD | 30.47% |
| 2022 | 38.87 Million USD | 3.56% |
| 2021 | 37.53 Million USD | 137.4% |
| 2020 | 15.81 Million USD | 20.72% |
| 2019 | 13.09 Million USD | 10.67% |
| 2018 | 11.83 Million USD | 249.66% |
| 2017 | 3.38 Million USD | 111.46% |
| 2016 | 1.6 Million USD | -3.4% |
| 2015 | 1.65 Million USD | 131.57% |
| 2014 | 715.56 Thousand USD | 34.31% |
| 2013 | 532.76 Thousand USD | -29.49% |
| 2012 | 755.62 Thousand USD | 58.66% |
| 2011 | 476.24 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 15.61 Million USD | 11.04% |
| 2024 Q1 | 14.36 Million USD | -1.68% |
| 2023 Q2 | 12.36 Million USD | 22.34% |
| 2023 Q4 | 14.61 Million USD | 7.16% |
| 2023 Q1 | 10.1 Million USD | 12.79% |
| 2023 Q3 | 13.63 Million USD | 10.28% |
| 2023 FY | 50.72 Million USD | 30.47% |
| 2022 Q1 | 9.91 Million USD | -30.58% |
| 2022 Q3 | 10.24 Million USD | 5.01% |
| 2022 Q4 | 8.96 Million USD | -12.53% |
| 2022 FY | 38.87 Million USD | 3.56% |
| 2022 Q2 | 9.75 Million USD | -1.58% |
| 2021 Q2 | 6.61 Million USD | 29.06% |
| 2021 Q4 | 14.27 Million USD | 23.89% |
| 2021 Q1 | 5.12 Million USD | 30.02% |
| 2021 FY | 37.53 Million USD | 137.4% |
| 2021 Q3 | 11.52 Million USD | 74.35% |
| 2020 FY | 15.81 Million USD | 20.72% |
| 2020 Q1 | 3.87 Million USD | 16.72% |
| 2020 Q2 | 3.6 Million USD | -6.84% |
| 2020 Q3 | 4.38 Million USD | 21.64% |
| 2020 Q4 | 3.93 Million USD | -10.25% |
| 2019 Q1 | 2.48 Million USD | -71.47% |
| 2019 Q4 | 3.31 Million USD | -10.98% |
| 2019 Q3 | 3.72 Million USD | 4.2% |
| 2019 FY | 13.09 Million USD | 10.67% |
| 2019 Q2 | 3.57 Million USD | 44.07% |
| 2018 Q2 | 7.46 Million USD | 392.74% |
| 2018 Q4 | 8.7 Million USD | 762.89% |
| 2018 Q1 | 1.51 Million USD | 50.91% |
| 2018 FY | 11.83 Million USD | 249.66% |
| 2018 Q3 | 1 Million USD | -86.49% |
| 2017 FY | 3.38 Million USD | 111.46% |
| 2017 Q4 | 1 Million USD | -20.62% |
| 2017 Q1 | 540.22 Thousand USD | -7.43% |
| 2017 Q2 | 644.22 Thousand USD | 19.25% |
| 2017 Q3 | 1.26 Million USD | 96.41% |
| 2016 Q1 | 283.67 Thousand USD | -60.22% |
| 2016 FY | 1.6 Million USD | -3.4% |
| 2016 Q4 | 583.55 Thousand USD | 47.44% |
| 2016 Q3 | 395.79 Thousand USD | 18.28% |
| 2016 Q2 | 334.62 Thousand USD | 17.96% |
| 2015 Q1 | 276.79 Thousand USD | -29.04% |
| 2015 Q3 | 273.26 Thousand USD | -30.61% |
| 2015 FY | 1.65 Million USD | 131.57% |
| 2015 Q4 | 713.18 Thousand USD | 160.99% |
| 2015 Q2 | 393.78 Thousand USD | 42.27% |
| 2014 Q4 | 390.05 Thousand USD | 315.1% |
| 2014 FY | 715.56 Thousand USD | 34.31% |
| 2014 Q3 | 93.96 Thousand USD | -2.2% |
| 2014 Q2 | 96.07 Thousand USD | -29.08% |
| 2014 Q1 | 135.47 Thousand USD | -14.35% |
| 2013 Q3 | 93.3 Thousand USD | -17.64% |
| 2013 Q4 | 158.18 Thousand USD | 69.53% |
| 2013 FY | 532.76 Thousand USD | -29.49% |
| 2013 Q1 | 167.98 Thousand USD | -56.45% |
| 2013 Q2 | 113.28 Thousand USD | -32.56% |
| 2012 Q3 | 167.39 Thousand USD | 24.59% |
| 2012 Q4 | 385.76 Thousand USD | 130.46% |
| 2012 Q2 | 134.35 Thousand USD | 97.22% |
| 2012 Q1 | 68.12 Thousand USD | 0.0% |
| 2012 FY | 755.62 Thousand USD | 58.66% |
| 2011 Q2 | 315.16 Thousand USD | 0.0% |
| 2011 FY | 476.24 Thousand USD | 0.0% |
| 2011 Q3 | 113.01 Thousand USD | -64.14% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aion Therapeutic Inc. | 163.11 Thousand CAD | -31493.274% |
| Ayurcann Holdings Corp. | 11.71 Million CAD | -339.852% |
| Blueberries Medical Corp. | 84.22 Thousand CAD | -61086.109% |
| The BC Bud Corporation | 1.28 Million CAD | -3916.736% |
| BioNxt Solutions Inc. | 6.73 Million CAD | -664.65% |
| CordovaCann Corp. | 3.86 Million CAD | -1234.527% |
| Christina Lake Cannabis Corp. | 4.28 Million CAD | -1103.175% |
| Captor Capital Corp. | 16.28 Million CAD | -216.502% |
| City View Green Holdings Inc. | 705.7 Thousand CAD | -7202.443% |
| 1CM Inc. | 7.3 Million CAD | -605.182% |
| Global Hemp Group Inc. | 551.7 Thousand CAD | -9240.811% |
| Greenway Greenhouse Cannabis Corporation | 4.8 Million CAD | -971.924% |
| IM Cannabis Corp. | 22.63 Million CAD | -127.644% |
| Lobe Sciences Ltd. | 4.13 Million CAD | -1147.129% |
| Maple Leaf Green World Inc. | 392.21 Thousand CAD | -13039.189% |
| Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -85790.0% |
| Nextleaf Solutions Ltd. | 1.76 Million CAD | -2814.803% |
| Ovation Science Inc. | 54.1 Thousand CAD | -95156.932% |
| Pharmadrug Inc. | 1.33 Million CAD | -3760.187% |
| Captiva Verde Wellness Corp. | 1.3 Million CAD | -3847.734% |
| RAMM Pharma Corp. | 7.48 Million CAD | -588.921% |
| RIV Capital Inc. | 21.1 Million CAD | -144.21% |
| Revive Therapeutics Ltd. | 3.28 Million CAD | -1468.425% |
| Red White & Bloom Brands Inc. | 37.75 Million CAD | -36.48% |
| SLANG Worldwide Inc. | 24.6 Million CAD | -109.438% |
| 1933 Industries Inc. | 5.12 Million CAD | -905.494% |
| Red Light Holland Corp. | 2.02 Million CAD | -2450.597% |
| Top Strike Resources Corp. | 3.63 Million CAD | -1318.985% |
| Xebra Brands Ltd. | -308.42 Thousand CAD | 16808.925% |
| Adastra Holdings Ltd. | 9.36 Million CAD | -450.542% |